Loading…
Based on limited metadata, this warning letter issued to Ecometics, Inc. in April 2019 concerns drug products and indicates regulatory violations, though the specific nature of the violations cannot be determined without access to the full letter text. The FDA took action against the company under its drug regulatory authority, but without the subject line or detailed violation information, the exact compliance issues—whether related to manufacturing, labeling, safety, or another aspect—remain unclear. To understand the specific violations and required corrective actions, review of the complete warning letter would be necessary.